DDrare: Database of Drug Development for Rare Diseases

Teicoplanin (DrugBank: Teicoplanin)

2 diseases

ID	Disease name (Link within this page)	Number of trials
70	Spinal stenosis	1
299	Cystic fibrosis	1

70. Spinal stenosis [ 91 clinical trials, 195 drugs, (DrugBank: 54 drugs), 60 drug target genes, 85 drug target pathways]

Searched query = "Spinal stenosis", "Extensive spinal canal stenosis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

1 / 91 trial found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04341831 (ClinicalTrials.gov)	April 15, 2020	8/4/2020	Does Teicoplanin Powder Use In Lumbar Instrumentation Surgery Reduce Surgical Site Infection	Does Teicoplanin Powder Use In Lumbar Instrumentation Surgery Reduce Surgical Site Infection	Lumbar Spinal Stenosis;Lumbar Disc Herniation;Scoliosis Lumbar Region;Lumbar Spondylolisthesis;Lumbar Disc Lesion	Drug: Teicoplanin	Bezmialem Vakif University	NULL	Not yet recruiting	18 Years	N/A	All	120	Phase 3	NULL

299. Cystic fibrosis [ 1,592 clinical trials, 1,539 drugs, (DrugBank: 255 drugs), 81 drug target genes, 162 drug target pathways]

Searched query = "Cystic fibrosis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

1 / 1,592 trial found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04176328 (ClinicalTrials.gov)	October 25, 2019	8/11/2019	Open-label, Dose-escalation Study to Evaluate the Pharmacokinetics of Inhaled Teicoplanin in Cystic Fibrosis Patients	An Open-label, Dose-escalation Study to Evaluate the Pharmacokinetics of Inhaled Teicoplanin in Cystic Fibrosis Patients	Cystic Fibrosis	Drug: Teicoplanin Sandoz 200 mg powder and solvent for solution for injection or infusion or oral solution.	Neupharma Srl	Sintesi Research Srl;Aptuit Srl;Pari Pharma GmbH	Completed	18 Years	N/A	All	12	Phase 1	Italy